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ABSTRACT 
STK-15 protein or Aurora-A kinase play a vital role in regulating the cell 
division process. This preliminary study was conducted to investigate the association 
of polymorphisms Phe3llle with colorectal cancer development. This non- 
synonymous coding region was believed to have important function in regulating the 
periodically proteasomal-ubiquitination degrading mechanism of STK-15 protein. To 
examine whether functional variation in STK-15 may affect the susceptible risk, DNA 
samples from colorectal cancer patients (n = 11) and healthy individual (n = 1) were 
genotyped for Phe31IIe polymorphisms. Polymerase chain reaction-restriction 
fragment length polymorphism was used in this study. A restriction enzyme cutting 
site of Apol is created when there is a polymorphism. Out of 11 samples, 9.09% were 
Phe/Phe genotype, 72.73% were Phe/Ile genotype and 18.18% were Ile/Ile genotype. 
The heterozygous might possibly have the highest risk in developing colorectal 
cancer. The samples were in Hardy-Weinberg-proportion (X2 = 2.393, N=11). Risk of 
association between polymorphisms of Phe3llle in both alleles and colorectal cancer 
were investigated using OR, allele Ile was found to have high susceptibility risk 
(OR=1.20,95% CI = 0.1-22.0) as compared to allele Phe. However, acting as a 
preliminary study, data obtained indicated that high occurrence rate of Phe3IIle 
polymorphism can be found in colorectal cancer individuals and it is worth to conduct 
a large scale and well designed study in the future. 
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PENENTUAN GENOTIP POLIMOFISME GEN PENEMBUSAN RENDAH, 
STK-15 DALAM KOLOREKTAL KANSER 
ABSTRAK 
Protein STK-15 atau Aurora-A kinase memainkan peranan yang penting dalam 
mengawal proses pembahagian sel. Kajian primary ini telah dijalankan untuk 
mengkaji hubungan antara polimofisme pada bahagian Phe3l Ile dengan penghidapan 
penyakit kolorektal kanser. Ketidak-synonymous pada bahagian ini dipercayai 
mempunyai peranan yang penting dalam mengawal proses mekanisma penghapusan 
protein STK-15 melalui ubiquitin yang berlaku pada masa yang tertentu. Demi 
mangkaji samada variasi yang berfungsi dalam protein STK-15 ini akan menjejaskan 
kadar penghidapan penyakit kolorektal kanser, sampel DNA daripada penghidap 
penyakit kolorektal kanser" (n = 11) dan seorang individu yang sihat (n = 1) telah 
menjalani kajian penentuan genotip polimofisme pada bahagian Phe3lIle. Kaedah 
tindak balas rantai polimerase-pembatasan kepanjangan jujukan DNA polimofisme 
telah digunakan dalam kajian ini, pemotongan pada bahagian yang tertentu oleh Apol 
akan berlaku apabila mempunyai polimofisme. Daripada sebelas sampel yang 
dikumpul, 9.09% adalah Phe/Phe genotip, 72.73% adalah Phe/Ile genotip dan 18.18% 
adalah lie/lie genotip. Genotip heterozigot dipercayai mungkin mempunyai kadar 
risiko penghidapan penyakit kolorektal kanser yang paling tinggi. Kesemua sampel 
berada dalam keseimbangan Hardy-Weinberg (X2 = 2.393, N=11). Hubungan antara 
kadar risiko penghidapan penyakit kolorektal kanser dan Phe3l Ile polimofisme dalam 
kedua-dua alle telah dikaji menggunakan kaedah nisbah keganjilan (OR), alle lie 
didapati mempunyai kadar risiko yang tertinggi dalam sehubung dengan penyakit 
kolorektal kanser ini (OR = 1.20,95% CI = 0.1-22.0) berbanding dengan alle Phe. 
Walaubagaimanapun, sebagai kajian primary, data daripada kajian ini jelas 
menunjukkan bahawa terdapat kadar polimofisme Phe3lIle yang tinggi dalam pesakit 
kolorektal kanser, ini menunjukkan bahawa adalah berbaloi untuk menjalankan kajian 
ini dengan saiz sampel yang besar pada masa akan datang. 
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STK-15, which is also known as Aurora-A, Aurora-2 or Breast Tumour 
Amplified Kinase (abbreviated as BTAK for its first discoveries in breast tumour), 
can be clarified also as STK-6 for its homologues found in Drosophila melanogaster 
or AIR-1 in C. elegans. STK-15 belongs to one of the family of mitotic kinases, 
which is a type of serine/threonine kinases, primary known as Aurora kinases/Ipll- 
related kinases. (Dai et a!., 2004; Marumoto et al., 2005). Research and studies have 
been conducted to show that the Aurora kinases play vital role in regulating the 
progression of cell cycle especially in controlling some of the major events like 
centrosome maturation, chromosome condensation, centrosome separation, 
degradation of nuclear-envelope, the congregation of bipolar-spindle, chromosome 
segregation and the process of cytokinesis (Zhou et a!., 1998; Gritsko et al., 2003; Li 
et al., 2003; Marumoto et al., 2005). 
2 
Studies have shown that human comprises three classes of Aurora kinases- 
Aurora-A, Aurora-B and Aurora C. Research had also indicated that all the three 
classes of Aurora kinases are involved in the development of different types of cancer. 
However, in this research, only the class STK-15/Aurora-A will be further elucidated. 
STK-15/Aurora-A is being found to express mostly in all the types of cells and 
specifically, the protein STK-15/Aurora-A is being coded by the gene STK-15 is 
found to be located on the chromosome 20q 13.2. 
As for this dissertation, we are going to examine the effect of the mechanism 
of polymorphisms on this putative oncogene STK-15/Aurora-A specifically for 
colorectal cancer patients. Research has shown that STK-15/Aurora-A is being 
overexpressed and amplified during the progression of cell-cycle and leads to the 
development of cancer. Many types of cancer are involved such as breast cancer, 
colorectal cancer, pancreatic cancer (Li et al., 2003), prostate cancer, ovarian cancer, 
neuroblastoma cancer, cervical cancer, lung cancer, renal cancer, gastric cancer and 
melanoma cell lines. (Bischoff et al., 1998; Zhou et al., 1998). 
However, polymorphisms of STK15/Aurora-A is not the sole cause that leads 
to the onset of colorectal cancer since it also possesses three other major reasons such 
as the mutations in tumour suppressor genes, oncogenes and DNA mismatch repair 
genes. Since both polymorphisms and the presence of low penetrance genes have 
been the useful biomarkers for the signal of cancer development, therefore, both 
searching for polymorphisms and low penetrance genes have been utilized as one of 
the effective methodology in knowing the potential of a patient to develop cancer at 
the present days. 
3 
Despite there have been numerous volumes of literatures regarding the 
colorectal cancer at the present days, patients developing this type of cancer had never 
been reduced. In year 2006, there were more than 55,000 cases of death solely 
belongs to colorectal patients in United States (Hung et al., 2006) and as for Malaysia, 
colorectal cancer had become the leading type of diseases. This entire phenomenon 
conveys a message for us that there is still a compelling need to search for new 
therapies and detection methods for this cancer. 
1.2 Objectives 
The Main Objectives of this dissertation are: 
(i) To extract DNA from biopsy samples of colorectal cancer. 
(ii) To test the presence of Phe3l Ile single nucleotide polymorphism (SNP) in 
putative oncogene STKI S/Aurora-A. 
(iii) To investigate to what extent the single nucleotide polymorphism of 




2.1 What is Colorectal Cancer? 
Colon Cancer or more accurately being known as colorectal cancer is being defined as 
clusters of malignant (cancerous) cells form and develop surrounding the tissues of 
the colon organ within our stomach (Feldman et al., 2002; Warrell et al., 2003). 
2.1.1 The Biology of Normal Colon 
As in a normal condition of the organ colon, it comprises a single layer of column-like 
shape of epithelial cells which are being organized into invaginations, primary known 
as crypts. When we observed carefully, we will be able to discover that those crypts 
can actually being subdivided into two distinct zones. The first zone belongs to a 
proliferative compartment, which comprises cells at the bottom portion of the crypts. 
While for the second zone, it comprises cells in the upper portion of the crypts and 
this zone is known as differentiated zone (Warrell et al., 2003). 
5 
2.1.2 The Biology of Colorectal Cancer 
Colorectal cancer can only be onset when a structure known as polyps started to 
develop. This polyps structure basically can be defined as a growth arising from the 
intestine itself, protruding into the lumen of the colon. Sometimes also being known 
as lesions and these polyps can be seen through naked eyes (visible). 
This polyps basically can be arisen from different parts of the colon, 
sometimes it might arise from subepithelial tissues and sometimes it might arise from 
the intestinal epithelium. Polyps arising from the latter can be the matter of life and 
death since it can be the precursor for the development of colorectal adenocarcinomas. 
When we come across the disease cancer, we can classify its severity based on its 
histology. As for the disease of cancer, term "benign" is used for no life-threatening 141 
coo T 
condition and the term "malignant" for harmful or likely to cause death. ti 
]s 
Ä 
Polyps have the same situation at where whether it is benign or malignant, 
thoroughly based on its histology. As for colorectal cancer, we have the term "non- 
neoplastic" for benign or very unlikely to transform into malignancies and 
"neoplastic" for malignant or very likely to develop malignancies (Kim and Lance, 
1997). Under the histology studies, colorectal cancer will be declared officially when 
a neoplastic stage has achieved. However, a recent study on hyperplastic polyps, 
which is the enlargement or unusual growth within the colon, which is normally cause 
by an abnormal increased of cells do shown an increased risk in developing colorectal 
cancer (Rashid et al., 2000). 
6 
As for neoplastic in colorectal cancer is known as adenomatous polyps. 
Patients who develop these polyps are very likely or have higher percentage to 
develop malignancies. They can be further classifies into low-, medium- and high- 
grade. As in high-grade stage, the polyps normally can reach the size of about 1 cm 
and are villous (hairy) (Appel et al., 1977). Study has also shown that in order to 
develop colorectal cancer from small polyps, normally it has to take eleven years to 
bring it on (Stryker et al., 1987). 
Studies have also proven that the locations of those polyps are also affecting 
the development of colorectal cancer. According to the studies, polyps locating at the 
left side of the colon will be more susceptible to develop colorectal cancer (Vatn M. H 
and Stalsberg H., 1982; Williams et al., 1982; Coode et al., 1985; Johannsen et al., 
1989). 
2.2 The Genetics of Colorectal Cancer 
One of the causes for colorectal cancer (CRC), in fact we should say that this is the 
major cause contributing to the development of CRC, will be the mutations of certain 
genes. CRC arise from mutations in multiple cancer causing-genes in colonic 
epithelial cells, at where it had been mentioned by Balmain and his colleagues that 
most cancer is a polygenic disorder (Balmain et al., 2003). 
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